www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

AstraZeneca to develop new drugs with Chinese partner

chinadaily.com.cn | Updated: 2017-11-28 14:25

AstraZeneca on Monday announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China to discover, develop and commercialise potential new medicines to help meet unmet needs globally, and to bring innovative new medicines to patients in China faster. FIIF is managed by the SDIC Fund Management Company (SDIC Fund), a fully market-oriented and professional private equity management company.

The new company, Dizal Pharmaceutical, incorporates all scientific and technical capabilities of AstraZeneca's Innovation Center China (ICC), and holds exclusive rights to develop and commercialise three potential medicines currently in pre-clinical development from AstraZeneca's pipeline in its main therapy areas of oncology, cardiovascular and metabolic diseases, and respiratory. It is also expected to initiate novel clinical programmes. The SDIC Fund will contribute funding and expertise in establishing strategic partnerships in China.

Dr. Xiaolin Zhang, previously Head of AstraZeneca's ICC, has been named as Chief Executive Officer of the new company.All staff employed by the ICC have been invited to join the new company.

Pascal Soriot, Chief Executive Officer of AstraZeneca, said: "AstraZeneca has a long-standing and strong commitment to China, which we are reinforcing today with this ground-breaking joint venture. By joining forces with the SDIC Fund, we aim to accelerate the local discovery and development of innovative, affordable medicines for patientsin China and around the world."

Guohua Gao, Chairman of SDIC Fund, said: "SDIC Fund is delighted to be collaborating with AstraZeneca to promote the development of innovative medicines. AstraZeneca's Innovation Center China has an excellent track record of drug discovery, and the synergy created by combining AstraZeneca's scientific talent and assets with SDIC Fund's China expertise and funding will help further promote innovation in medical science."

The remit of the SDIC Fund in the pharmaceutical industry is to promote the development and manufacturing of innovative medicines in China through strategic partnerships. The joint venture supports AstraZeneca's commitment to enhancing China's research and development capabilities through diversified external partnerships that deliver value to patients in China.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 亚洲精品久久久久久久网站 | 深夜在线观看大尺度 | 国产精品亚洲欧美日韩久久 | 亚洲欧美日韩国产制服另类 | 特黄a三级三级三级 | 亚洲第一中文 | 私人午夜影院 | 欧美成人看片一区二区三区尤物 | 和老外3p爽粗大免费视频 | 国产成人一区二区三区视频免费 | 成人久久18免费网站 | 亚洲热播 | 欧美成人伊人十综合色 | 波多结衣一区二区三区 | 一区二区三区四区在线免费观看 | 深夜福利视频在线观看 | 日韩欧美视频一区二区在线观看 | 日韩美女视频在线观看 | 澳门一级毛片手机在线看 | 国产成人精品免费视频大全五级 | 国产中文在线视频 | 国产精品久久久久久网站 | 久久综合免费视频 | 亚洲午夜精品久久久久久抢 | 久草综合视频在线 | 寡妇一级毛片 | 一区二区三区在线免费视频 | 在线色网址 | 久久精品国产99久久香蕉 | 国产一区欧美二区 | 日本高清色视频www 日本高清在线精品一区二区三区 | 伊人国产在线视频 | 久久久久久久久性潮 | 成年人网站免费在线观看 | 亚洲日韩中文字幕 | 欧美区一区 | 亚洲精品第一区二区三区 | 免费a网| 国产成人无精品久久久久国语 | 久久精品国产99久久99久久久 | 国产一区二区播放 |